Therapeutic Drug Monitoring Market Updates by 2031
Therapeutic drug monitoring is branch of clinical chemistry and clinical pharmacology. It helps to measure and maintain uniform drug concentration in the patients' blood stream for better outcome. Therapeutic drug monitoring is part of personalized medicine where measurement of medication concentration in the blood stream is necessary. Therapeutic drug monitoring is basically used in case of very specific drug concentrations requirement.
MARKET DYNAMICS
Therapeutic drug monitoring market is anticipated to grow in the forecast period owing to driving factors such as rising demand for personalized medication treatment, advancements in research of pharmacogenomics and pharmacokinetics of drugs, rising prevalence of complex diseases like cancer (rheumatoid arthritis, non-Hodgkin lymphomas), respiratory diseases such as neonatal apnea, pulmonary asthma, embolism and chronic obstructive pulmonary disease (COPD). Rising investments in research and development infrastructure by private players and government will drive the therapeutic drug monitoring market in near future. However, high infrastructure cost and lack of skilled professionals are the restraints of the therapeutic drug monitoring market.
MARKET SCOPE
The "Global Therapeutic Drug Monitoring Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of therapeutic drug monitoring market with detailed market segmentation by product, technology, drug class, end user, and geography. The global therapeutic drug monitoring market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading therapeutic drug monitoring market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global therapeutic drug monitoring market is segmented on the basis of product, technology, drug class, and end user. Based on product, the market is segmented as Equipment and consumables. On the basis of technology, the global therapeutic drug monitoring market is segmented in to immunoassays, chromatography-Ms, radioimmunoassays, and others. By drug class, the market is segmented into antibiotic drugs, antiepileptic drugs, antiarrhythmic drugs, bronchodilator drugs, immunosuppressant drugs, psychoactive drugs, anti-cancer drugs, and other drugs. On the basis of end user, the global therapeutic drug monitoring market is divided into hospital laboratories, private laboratories and other laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global therapeutic drug monitoring market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The therapeutic drug monitoring market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting therapeutic drug monitoring market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the therapeutic drug monitoring market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global therapeutic drug monitoring market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The therapeutic drug monitoring market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting therapeutic drug monitoring market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the therapeutic drug monitoring market in these regions.
MARKET PLAYERS
The reports cover key developments in the therapeutic drug monitoring market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from therapeutic drug monitoring market are anticipated to lucrative growth opportunities in the future with the rising demand for therapeutic drug monitoring in the global market. Below mentioned is the list of few companies engaged in the therapeutic drug monitoring market.
The report also includes the profiles of key therapeutic drug monitoring market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- Bühlmann Laboratories AG
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Randox Laboratories Ltd.
- Sekisui Medical Co. Ltd.
- Siemens Healthineers
- Thermo Fisher Scientific
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Therapeutic Drug Monitoring Market - By Product
1.3.2 Therapeutic Drug Monitoring Market - By Technology
1.3.3 Therapeutic Drug Monitoring Market - By Drug class
1.3.4 Therapeutic Drug Monitoring Market - By End User
1.3.5 Therapeutic Drug Monitoring Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. THERAPEUTIC DRUG MONITORING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.2.6 Rest of the World - Pest Analysis
4.3. EXPERT OPINIONS
5. THERAPEUTIC DRUG MONITORING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. THERAPEUTIC DRUG MONITORING MARKET - GLOBAL MARKET ANALYSIS
6.1. THERAPEUTIC DRUG MONITORING - GLOBAL MARKET OVERVIEW
6.2. THERAPEUTIC DRUG MONITORING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. THERAPEUTIC DRUG MONITORING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EQUIPMENT
7.3.1. Overview
7.3.2. Equipment Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
8. THERAPEUTIC DRUG MONITORING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAYS
8.3.1. Overview
8.3.2. Immunoassays Market Forecast and Analysis
8.4. CHROMATOGRAPHY-MS
8.4.1. Overview
8.4.2. Chromatography-MS Market Forecast and Analysis
8.5. RADIOIMMUNOASSAYS
8.5.1. Overview
8.5.2. Radioimmunoassays Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. THERAPEUTIC DRUG MONITORING MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
9.1. OVERVIEW
9.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
9.3. ANTIBIOTIC DRUGS
9.3.1. Overview
9.3.2. Antibiotic drugs Market Forecast and Analysis
9.4. ANTIEPILEPTIC DRUGS
9.4.1. Overview
9.4.2. Antiepileptic Drugs Market Forecast and Analysis
9.5. ANTIARRHYTHMIC DRUGS
9.5.1. Overview
9.5.2. Antiarrhythmic Drugs Market Forecast and Analysis
9.6. BRONCHODILATOR DRUGS
9.6.1. Overview
9.6.2. Bronchodilator Drugs Market Forecast and Analysis
9.7. IMMUNOSUPPRESSANT DRUGS
9.7.1. Overview
9.7.2. Immunosuppressant Drugs Market Forecast and Analysis
9.8. PSYCHOACTIVE DRUGS
9.8.1. Overview
9.8.2. Psychoactive Drugs Market Forecast and Analysis
9.9. ANTI-CANCER DRUGS
9.9.1. Overview
9.9.2. Anti-cancer drugs Market Forecast and Analysis
9.10. OTHER DRUGS
9.10.1. Overview
9.10.2. Other drugs Market Forecast and Analysis
10. THERAPEUTIC DRUG MONITORING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL LABORATORIES
10.3.1. Overview
10.3.2. Hospital laboratories Market Forecast and Analysis
10.4. PRIVATE LABORATORIES
10.4.1. Overview
10.4.2. Private laboratories Market Forecast and Analysis
10.5. OTHER LABORATORIES
10.5.1. Overview
10.5.2. Other laboratories Market Forecast and Analysis
11. THERAPEUTIC DRUG MONITORING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Therapeutic Drug Monitoring Market Overview
11.1.2 North America Therapeutic Drug Monitoring Market Forecasts and Analysis
11.1.3 North America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Product
11.1.4 North America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Technology
11.1.5 North America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Drug class
11.1.6 North America Therapeutic Drug Monitoring Market Forecasts and Analysis - By End User
11.1.7 North America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Countries
11.1.7.1 United States Therapeutic Drug Monitoring Market
11.1.7.1.1 United States Therapeutic Drug Monitoring Market by Product
11.1.7.1.2 United States Therapeutic Drug Monitoring Market by Technology
11.1.7.1.3 United States Therapeutic Drug Monitoring Market by Drug class
11.1.7.1.4 United States Therapeutic Drug Monitoring Market by End User
11.1.7.2 Canada Therapeutic Drug Monitoring Market
11.1.7.2.1 Canada Therapeutic Drug Monitoring Market by Product
11.1.7.2.2 Canada Therapeutic Drug Monitoring Market by Technology
11.1.7.2.3 Canada Therapeutic Drug Monitoring Market by Drug class
11.1.7.2.4 Canada Therapeutic Drug Monitoring Market by End User
11.1.7.3 Mexico Therapeutic Drug Monitoring Market
11.1.7.3.1 Mexico Therapeutic Drug Monitoring Market by Product
11.1.7.3.2 Mexico Therapeutic Drug Monitoring Market by Technology
11.1.7.3.3 Mexico Therapeutic Drug Monitoring Market by Drug class
11.1.7.3.4 Mexico Therapeutic Drug Monitoring Market by End User
11.2. EUROPE
11.2.1 Europe Therapeutic Drug Monitoring Market Overview
11.2.2 Europe Therapeutic Drug Monitoring Market Forecasts and Analysis
11.2.3 Europe Therapeutic Drug Monitoring Market Forecasts and Analysis - By Product
11.2.4 Europe Therapeutic Drug Monitoring Market Forecasts and Analysis - By Technology
11.2.5 Europe Therapeutic Drug Monitoring Market Forecasts and Analysis - By Drug class
11.2.6 Europe Therapeutic Drug Monitoring Market Forecasts and Analysis - By End User
11.2.7 Europe Therapeutic Drug Monitoring Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Therapeutic Drug Monitoring Market
11.2.7.1.1 Germany Therapeutic Drug Monitoring Market by Product
11.2.7.1.2 Germany Therapeutic Drug Monitoring Market by Technology
11.2.7.1.3 Germany Therapeutic Drug Monitoring Market by Drug class
11.2.7.1.4 Germany Therapeutic Drug Monitoring Market by End User
11.2.7.2 France Therapeutic Drug Monitoring Market
11.2.7.2.1 France Therapeutic Drug Monitoring Market by Product
11.2.7.2.2 France Therapeutic Drug Monitoring Market by Technology
11.2.7.2.3 France Therapeutic Drug Monitoring Market by Drug class
11.2.7.2.4 France Therapeutic Drug Monitoring Market by End User
11.2.7.3 Italy Therapeutic Drug Monitoring Market
11.2.7.3.1 Italy Therapeutic Drug Monitoring Market by Product
11.2.7.3.2 Italy Therapeutic Drug Monitoring Market by Technology
11.2.7.3.3 Italy Therapeutic Drug Monitoring Market by Drug class
11.2.7.3.4 Italy Therapeutic Drug Monitoring Market by End User
11.2.7.4 Spain Therapeutic Drug Monitoring Market
11.2.7.4.1 Spain Therapeutic Drug Monitoring Market by Product
11.2.7.4.2 Spain Therapeutic Drug Monitoring Market by Technology
11.2.7.4.3 Spain Therapeutic Drug Monitoring Market by Drug class
11.2.7.4.4 Spain Therapeutic Drug Monitoring Market by End User
11.2.7.5 United Kingdom Therapeutic Drug Monitoring Market
11.2.7.5.1 United Kingdom Therapeutic Drug Monitoring Market by Product
11.2.7.5.2 United Kingdom Therapeutic Drug Monitoring Market by Technology
11.2.7.5.3 United Kingdom Therapeutic Drug Monitoring Market by Drug class
11.2.7.5.4 United Kingdom Therapeutic Drug Monitoring Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Therapeutic Drug Monitoring Market Overview
11.3.2 Asia-Pacific Therapeutic Drug Monitoring Market Forecasts and Analysis
11.3.3 Asia-Pacific Therapeutic Drug Monitoring Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Therapeutic Drug Monitoring Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Therapeutic Drug Monitoring Market Forecasts and Analysis - By Drug class
11.3.6 Asia-Pacific Therapeutic Drug Monitoring Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Therapeutic Drug Monitoring Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Therapeutic Drug Monitoring Market
11.3.7.1.1 Australia Therapeutic Drug Monitoring Market by Product
11.3.7.1.2 Australia Therapeutic Drug Monitoring Market by Technology
11.3.7.1.3 Australia Therapeutic Drug Monitoring Market by Drug class
11.3.7.1.4 Australia Therapeutic Drug Monitoring Market by End User
11.3.7.2 China Therapeutic Drug Monitoring Market
11.3.7.2.1 China Therapeutic Drug Monitoring Market by Product
11.3.7.2.2 China Therapeutic Drug Monitoring Market by Technology
11.3.7.2.3 China Therapeutic Drug Monitoring Market by Drug class
11.3.7.2.4 China Therapeutic Drug Monitoring Market by End User
11.3.7.3 India Therapeutic Drug Monitoring Market
11.3.7.3.1 India Therapeutic Drug Monitoring Market by Product
11.3.7.3.2 India Therapeutic Drug Monitoring Market by Technology
11.3.7.3.3 India Therapeutic Drug Monitoring Market by Drug class
11.3.7.3.4 India Therapeutic Drug Monitoring Market by End User
11.3.7.4 Japan Therapeutic Drug Monitoring Market
11.3.7.4.1 Japan Therapeutic Drug Monitoring Market by Product
11.3.7.4.2 Japan Therapeutic Drug Monitoring Market by Technology
11.3.7.4.3 Japan Therapeutic Drug Monitoring Market by Drug class
11.3.7.4.4 Japan Therapeutic Drug Monitoring Market by End User
11.3.7.5 South Korea Therapeutic Drug Monitoring Market
11.3.7.5.1 South Korea Therapeutic Drug Monitoring Market by Product
11.3.7.5.2 South Korea Therapeutic Drug Monitoring Market by Technology
11.3.7.5.3 South Korea Therapeutic Drug Monitoring Market by Drug class
11.3.7.5.4 South Korea Therapeutic Drug Monitoring Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Therapeutic Drug Monitoring Market Overview
11.4.2 Middle East and Africa Therapeutic Drug Monitoring Market Forecasts and Analysis
11.4.3 Middle East and Africa Therapeutic Drug Monitoring Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Therapeutic Drug Monitoring Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Therapeutic Drug Monitoring Market Forecasts and Analysis - By Drug class
11.4.6 Middle East and Africa Therapeutic Drug Monitoring Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Therapeutic Drug Monitoring Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Therapeutic Drug Monitoring Market
11.4.7.1.1 South Africa Therapeutic Drug Monitoring Market by Product
11.4.7.1.2 South Africa Therapeutic Drug Monitoring Market by Technology
11.4.7.1.3 South Africa Therapeutic Drug Monitoring Market by Drug class
11.4.7.1.4 South Africa Therapeutic Drug Monitoring Market by End User
11.4.7.2 Saudi Arabia Therapeutic Drug Monitoring Market
11.4.7.2.1 Saudi Arabia Therapeutic Drug Monitoring Market by Product
11.4.7.2.2 Saudi Arabia Therapeutic Drug Monitoring Market by Technology
11.4.7.2.3 Saudi Arabia Therapeutic Drug Monitoring Market by Drug class
11.4.7.2.4 Saudi Arabia Therapeutic Drug Monitoring Market by End User
11.4.7.3 U.A.E Therapeutic Drug Monitoring Market
11.4.7.3.1 U.A.E Therapeutic Drug Monitoring Market by Product
11.4.7.3.2 U.A.E Therapeutic Drug Monitoring Market by Technology
11.4.7.3.3 U.A.E Therapeutic Drug Monitoring Market by Drug class
11.4.7.3.4 U.A.E Therapeutic Drug Monitoring Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Therapeutic Drug Monitoring Market Overview
11.5.2 South and Central America Therapeutic Drug Monitoring Market Forecasts and Analysis
11.5.3 South and Central America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Product
11.5.4 South and Central America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Drug class
11.5.6 South and Central America Therapeutic Drug Monitoring Market Forecasts and Analysis - By End User
11.5.7 South and Central America Therapeutic Drug Monitoring Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Therapeutic Drug Monitoring Market
11.5.7.1.1 Brazil Therapeutic Drug Monitoring Market by Product
11.5.7.1.2 Brazil Therapeutic Drug Monitoring Market by Technology
11.5.7.1.3 Brazil Therapeutic Drug Monitoring Market by Drug class
11.5.7.1.4 Brazil Therapeutic Drug Monitoring Market by End User
11.5.7.2 Argentina Therapeutic Drug Monitoring Market
11.5.7.2.1 Argentina Therapeutic Drug Monitoring Market by Product
11.5.7.2.2 Argentina Therapeutic Drug Monitoring Market by Technology
11.5.7.2.3 Argentina Therapeutic Drug Monitoring Market by Drug class
11.5.7.2.4 Argentina Therapeutic Drug Monitoring Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. THERAPEUTIC DRUG MONITORING MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AGILENT TECHNOLOGIES, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIO-RAD LABORATORIES INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIOMéRIEUX SA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BüHLMANN LABORATORIES AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. DANAHER CORPORATION
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. F. HOFFMANN-LA ROCHE LTD
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. RANDOX LABORATORIES LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SEKISUI MEDICAL CO. LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SIEMENS HEALTHINEERS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. THERMO FISHER SCIENTIFIC
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Abbott Laboratories
2. Agilent Technologies, Inc.
3. Bio-Rad Laboratories Inc.
4. bioMerieux SA
5. Bühlmann Laboratories AG
6. Danaher Corporation
7. F. Hoffmann-La Roche Ltd
8. Randox Laboratories Ltd.
9. Siemens Healthineers
10. Thermo Fisher Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For